[1] Nagaiah G, Hossain A, Mooney CJ, et al.Anaplastic Thyroid Cancer: A Review of Epidemiology, Pathogenesis, and Treatment[J]. J Oncol, 2011, 2011: 542358. [2] Kanazawa S, Kammori M.Case Report: 84-Month Disease-Free Survival after Surgery for Anaplastic Thyroid Carcinoma[J]. J Nippon Med Sch, 2019, 86(1): 38-42. [3] Sugitani I, Kasai N, Fujimoto Y, et al.Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid[J]. World J Surg, 2001, 25(5): 617-622. [4] Glaser SM, Mandish SF, Gill BS, et al.Anaplastic thyroid cancer: Prognostic factors, patterns of care, and overall survival[J]. Head Neck, 2016, 38(Suppl 1): E2083-E2090. [5] Paunovic IR, Sipetic SB, Zoric GV, et al.Survival and prognostic factors of anaplastic thyroid carcinoma[J]. Acta Chir Belg, 2015, 115(1): 62-67. [6] Lennon P, Deady S, Healy ML, et al.Anaplastic thyroid carcinoma: Failure of conventional therapy but hope of targeted therapy[J]. Head Neck, 2016, 38(Suppl 1): E1122-E1129. [7] 许翔, 杨筱, 赵瑞娜, 等. 甲状腺未分化癌和乳头状癌超声成像特征的差异[J]. 中国医学科学院学报, 2015, 37(1): 71-74. [8] Suh HJ, Moon HJ, Kwak JY, Choi JS, Kim EK.Anaplastic thyroid cancer: ultrasonographic findings and the role of ultrasonography-guided fine needle aspiration biopsy[J]. Yonsei Med J, 2013, 54(6): 1400-1406. [9] Ha EJ, Baek JH, Lee JH, et al.Core needle biopsy could reduce diagnostic surgery in patients with anaplastic thyroid cancer or thyroid lymphoma[J]. Eur Radiol, 2016, 26(4): 1031-1036. [10] Nikiforov YE, Seethala RR, Tallini G, et al.Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma A Paradiam Shift to Reduce Overtreatment of Indolent Tumors[J]. JAMA Oncol, 2016, 2(8): 1023-1029. [11] Gopal PP, Montone KT, Baloch Z, et al.The variable presentations of anaplastic spindle cell squamous carcinoma associated with tall cell variant of papillary thyroid carcinoma[J]. Thyroid, 2011, 21(5): 493-499. [12] Juhlin CC, Höög A.Clear cell variant of papillary thyroid carcinoma with associated anaplastic thyroid carcinoma: description of an extraordinary case[J]. Int J Surg Pathol, 2019, 27(6): 658-663. [13] Hu S, Helman SN, Hanly E, Likhterov I.The role of surgery in anaplastic thyroid cancer: A systematic review[J]. Am J Otolaryngol, 2017, 38(3): 337-350. [14] Goffredo P, Thomas SM, Adam MA, et al.Impact of timeliness of resection and thyroidectomy margin status on survival for patients with anaplastic thyroid cancer: an analysis of 335 cases[J]. Ann Surg Oncol, 2015, 22(13): 4166-4174. [15] Lin B, Ma H, Ma M, et al.The incidence and survival analysis for anaplastic thyroid cancer: a SEER database analysis[J]. Am J Transl Res, 2019, 11(9): 5888-5896. [16] Fan D, Ma J, Bell AC, et al.Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancer[J]. Cancer, 2020, 126(2): 444-452. [17] So K, Smith RE, Davis SR.Radiotherapy in anaplastic thyroid carcinoma: An Australian experience[J]. J Med Imaging Radiat Oncol, 2017, 61(2): 279-287. [18] Kwon J, Kim BH, Jung HW, et al.The prognostic impacts of postoperative radiotherapy in the patients with resected anaplastic thyroid carcinoma: A systematic review and meta-analysis[J]. Eur J Cancer, 2016, 59: 34-45. |